Clinical Trial Update: Phase IIa Study on Flonoltinib Maleate Tablets in the Treatment of Patients With Polycythemia Vera [Phase 2]

View source ↗

Summary

Phase IIa study of Flonoltinib Maleate Tablets for polycythemia vera is currently recruiting. The sponsor is Chengdu Zenitar Biomedical Technology Co., Ltd.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycythemia Vera

Drugs mentioned

• Flonoltinib Maleate Tablets (Flonoltinib maleate)

Snippet

Sponsor: Chengdu Zenitar Biomedical Technology Co., Ltd | Conditions: Polycythemia Vera (PV) | Phase 2 | Status: RECRUITING